Analyst Ratings for Emerson (EMR) [Neutrals]
EMR Rating Summary
EMR Price Target Summary
- Highest: $70.00 (RBC Capital)
- Lowest: $47.00 (MKM Partners)
- Average: $58.25
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$58.25 (+1.6%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/8/2013 | Bernstein | Downgrade | Market Perform (Outperform) |
N/A (N/A) |
56.56 | 57.34 | 1.38% | Details |
| 3/28/2013 | Canaccord Genuity | New Coverage | Hold (N/A) |
60.00 (N/A) |
55.36 | 57.34 | 3.58% | Details |
| 3/21/2013 | Goldman Sachs | New Coverage | Neutral (N/A) |
62.00 (N/A) |
57.11 | 57.34 | 0.4% | Details |
| 2/6/2013 | Langenberg & Company | Downgrade | Hold (Buy) |
N/A (N/A) |
56.91 | 57.34 | 0.76% | Details |
| 1/8/2013 | Morgan Stanley | Downgrade | Equalweight (Overweight) |
N/A (N/A) |
54.70 | 57.34 | 4.83% | Details |
| 12/6/2012 | BofA/Merrill Lynch | New Coverage | Neutral (N/A) |
55.00 (N/A) |
50.65 | 57.34 | 13.21% | Details |
| 11/20/2012 | Oppenheimer » Updated 2/4/2013 |
Downgrade | Perform (Outperform) |
63.00 (55.00) |
48.95 | 57.34 | 17.14% | Details |
| 10/1/2012 | Macquarie | Downgrade | Neutral (Outperform) |
N/A (N/A) |
48.27 | 57.34 | 18.79% | Details |
| 9/14/2012 | Janney Montgomery Scott | New Coverage | Neutral (N/A) |
54.00 (N/A) |
49.97 | 57.34 | 14.75% | Details |
| 10/14/2011 | Barclays | New Coverage | Equalweight (N/A) |
55.00 (N/A) |
46.38 | 57.34 | 23.63% | Details |
| 9/28/2011 | MKM Partners | New Coverage | Neutral (N/A) |
47.00 (N/A) |
44.07 | 57.34 | 30.11% | Details |
| 8/30/2011 | Argus | Downgrade | Hold (N/A) |
N/A (N/A) |
46.88 | 57.34 | 22.31% | Details |
| 6/9/2011 | William Blair | New Coverage | Market Perform (N/A) |
N/A (N/A) |
51.43 | 57.34 | 11.49% | Details |
